(Total Views: 490)
Posted On: 05/27/2021 11:40:56 AM
Post# of 154092
Worth sharing from YMB.
Dr. Berwanger at AE is da man: Our Brazil Critical contact: Otavio Berwanger, MD, PhD
Director of the Academic Research Organization (ARO) at Hospital Israelita Albert Einstein
About
Dr Berwanger (MD; PhD) is a cardiologist and clinical trialist who has been working as Chair of the Steering Committee and Global Study Director of large-scale randomized clinical trials and Real World Evidence Studies. He coordinates a network of 167 Cardiovascular Research Sites in 10 countries (Brazil, Autralia, New Zealand, Canada, China, Russia, Ukraine, Argentina, Peru and Colombia). He is currently the Director of the largest clinical trials unit in South America (ARO- Hospital Israelita Albert Einstein) in Sao Paulo-SP, Brazil. He was the main presenter of over 10 clinical trials in late-breaking clinical trial sessions at the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions and European Congress of Cardiology-ESC. He has published manuscripts in major medical journals such as JAMA, New England Journal of Medicine, Lancet, Circulation, JACC and the European Heart Journal. Dr Berwanger´s current interests includes the conduct of innovative clinical trial models using Big Data, Artificial Intelligence and Machine Learning Techniques, as well as the use of wearables and devices to obtain patient reported-outcomes.
Dr. Berwanger at AE is da man: Our Brazil Critical contact: Otavio Berwanger, MD, PhD
Director of the Academic Research Organization (ARO) at Hospital Israelita Albert Einstein
About
Dr Berwanger (MD; PhD) is a cardiologist and clinical trialist who has been working as Chair of the Steering Committee and Global Study Director of large-scale randomized clinical trials and Real World Evidence Studies. He coordinates a network of 167 Cardiovascular Research Sites in 10 countries (Brazil, Autralia, New Zealand, Canada, China, Russia, Ukraine, Argentina, Peru and Colombia). He is currently the Director of the largest clinical trials unit in South America (ARO- Hospital Israelita Albert Einstein) in Sao Paulo-SP, Brazil. He was the main presenter of over 10 clinical trials in late-breaking clinical trial sessions at the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions and European Congress of Cardiology-ESC. He has published manuscripts in major medical journals such as JAMA, New England Journal of Medicine, Lancet, Circulation, JACC and the European Heart Journal. Dr Berwanger´s current interests includes the conduct of innovative clinical trial models using Big Data, Artificial Intelligence and Machine Learning Techniques, as well as the use of wearables and devices to obtain patient reported-outcomes.
(13)
(0)
